Cart
sales@molnova.com
Oxypurinol
CAS No. 2465-59-0
Oxypurinol( Alloxanthine | NSC 76239 )
Catalog No. M13717 CAS No. 2465-59-0
Oxypurinol, an inhibitor of xanthine oxidase, is a metabolite of allopurinol. .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 27 | In Stock |
|
| 25MG | 43 | In Stock |
|
| 50MG | 59 | In Stock |
|
| 100MG | 80 | In Stock |
|
| 200MG | 105 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOxypurinol
-
NoteResearch use only, not for human use.
-
Brief DescriptionOxypurinol, an inhibitor of xanthine oxidase, is a metabolite of allopurinol. .
-
DescriptionOxypurinol, an inhibitor of xanthine oxidase, is a metabolite of allopurinol. (In Vitro):Allopurinol is rapidly metabolized (half-life approximately 1 h) to its active metabolite oxypurinol. Oxypurinol is an inhibitor of xanthine oxidoreductase and has a considerably longer elimination half-life (approximately 23 h).
-
In Vitro——
-
In Vivo——
-
SynonymsAlloxanthine | NSC 76239
-
PathwayImmunology/Inflammation
-
TargetROS
-
RecptorXO
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2465-59-0
-
Formula Weight152.11
-
Molecular FormulaC5H4N4O2
-
Purity>98% (HPLC)
-
SolubilityLimited solubility
-
SMILESO=C(N1)C2=C(NN=C2)NC1=O
-
Chemical Name1,7-dihydro-4H-pyrazolo[3,4-d]pyrimidine-4,6(5H)-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Iwanaga T, et al. Drug Metab Dispos. 2005 Dec;33(12):1791-5.
molnova catalog
related products
-
Allopurinol
Allopurinol (Zyloprim) is a?xanthine oxidase?inhibitor with an?IC50?of 7.82±0.12 μM.
-
Zidesamtinib
Zidesamtinib (NVL-520) is an orally active, selective, potent, and blood-brain-barrier-crossing inhibitor of ROS1 fusion and resistance mutations, inhibits ROS1 and ROS1 G2032R, and can be used in the study of non-small-cell lung cancer and solid tumors.
-
Fagomine
Fagomine (D-Fagomine) is a mild glycosidase inhibitor, an analog of 1-deoxynojirimycin (DNJ) with hypoglycemic activity, and Fagomine reduces intracellular reactive oxygen species (ROS) production and malondialdehyde (MDA) levels.
